Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature

J Neurooncol. 2013 Sep;114(3):257-62. doi: 10.1007/s11060-013-1195-2. Epub 2013 Jul 2.


The aim of this study was to review the literature on quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis, and to identify the specific aspects of quality of life that were studied and reported in this population. We also set out to report predictors of quality of life. Published research reports were included if they described quality of life in this population and met methodological quality according to a list of predefined criteria. Eight studies (7 in NF1, 1 in NF2, 0 in schwannomatosis), conducted between 2001 and 2013, met inclusion criteria. The methodological quality of the eight studies was mostly high according to ratings by predefined criteria. Most studies reported that patients with NF experience decreased quality of life when compared to the general population. Visibility and disease severity were strong predictors of skin-specific quality of life in NF1 patients. However, the majority of findings regarding predictors of quality of life were weak or inconclusive. Given the decreased quality of life in NF patients, it is important to examine more comprehensively the psychosocial factors in this population, especially in patients with NF2 and schwannomatosis. Mind body interventions that address these domains may provide comprehensive and efficacious long term treatment.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Humans
  • Neurilemmoma / therapy*
  • Neurofibromatoses / therapy*
  • Neurofibromatosis 1 / therapy*
  • Neurofibromatosis 2 / therapy*
  • Quality of Life*
  • Review Literature as Topic
  • Skin Neoplasms / therapy*

Supplementary concepts

  • Schwannomatosis